Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography

Technology Revising Ultrasound Solutions for Tomorrow - Anticancer-treatment Cardiotoxicity Identification by Echocardiography

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

TRUST-ACE will compare a simplified echocardiographic protocol focusing on ventricular function with the guideline recommended comprehensive echocardiographic examination using a randomised design in follow-up of breast-cancer patients with respect to identification of cancer treatment related cardiac dysfunction (CTRCD). Secondly, the study will evaluate whether novel tools used to improve standardization of recordings as well as automated measurements of central measurements, e.g. ejection fraction (EF) and global longitudinal strain (GLS) can improve the precision of echocardiography in daily clinical practice.

Who May Be Eligible (Plain English)

Who May Qualify: - Breast cancer and referral for follow-up to identify potential CTRCD Who Should NOT Join This Trial: - Not willing or able to consent Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Breast cancer and referral for follow-up to identify potential CTRCD Exclusion Criteria: * Not willing or able to consent

Treatments Being Tested

DIAGNOSTIC_TEST

Comprehensive echocardiographic follow-up

Comprehensive echocardiographic follow-up for identification of CRTCD in breast cancer patients

DIAGNOSTIC_TEST

Simplified echocardiographic follow-up

Simplified echocardiographic follow-up for identification of CRTCD in breast cancer patients

Locations (1)

St. Olavs hospital
Trondheim, Norway